The Investor Relations website contains information about BioCryst Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial ...
People also ask
Is BCRX stock a good buy?
Why is BCRX dropping?
Who owns BCRX?
Is BioCryst a good company to work for?
We are BioCryst, a different kind of biotech company. Learn about our commitment to the rare disease patient community and discover career opportunities.
People also search for
Investor Relations Intelligence. Featured Solutions. Nasdaq Boardvantage® · Board Evaluations · Nasdaq IR Insight® · Nasdaq Metrio · See All Solutions ->. About.
According to Zacks Investment Research, based on 6 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.22. The reported EPS for the same ...
Find the latest BioCryst Pharmaceuticals, Inc. (BCRX) stock quote, history, news and other vital information to help you with your stock trading and ...
Missing: relations | Show results with:relations
(US:BCRX) has 431 institutional owners and shareholders ... NP, BLACKROCK FUNDS - iShares Total U.S. Stock Market Index Fund Investor ... relation to this website ...
Rating
(6,975)
Biocryst Pharmaceuticals (BCRX) will release its next earnings report on May 2, 2024. In the last quarter Biocryst Pharmaceuticals reported -$0.246 EPS in ...